Friday 6 November 2026 Export PRGO’s income statement to Excel — free account

Perrigo Company plc

PRGO Healthcare Drug Manufacturers Specialty & Generic

Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.

Revenue: −5.24%
EPS: −494.6%
Free cash flow: +138.5%
Total debt: −9.62%

Quarter to September 2026, against a year earlier

Dividend growth 10 yrs

15.66 0.17 −1.07%

Follow PRGO

Alert me

Market cap: $2.2B
P/E: 0.0×
Fwd P/E: −7.2×
Dividend yield: 7.41%
F-score: 4/9
Altman Z: −0.08
Beneish M: −3.51
Dividend safety: 16/100

Overview

Perrigo Company plc (PRGO) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Perrigo Company plc (PRGO) trades at a P/S ratio of 0.5×. Over the past ten years it has ranged from 0.3× (March 2026) to 8.2× (January 2016); the current reading is higher than 8% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PRGO/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Perrigo Company plc P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PRGO/metrics/ps-ratio">Perrigo Company plc (PRGO) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	0.5×	(43.88%)
FY2024	0.8×	(16.21%)
FY2023	1.0×	(9.38%)
FY2022	1.1×	(15.28%)
FY2021	1.3×	(15.66%)
FY2020	1.5×	(18.00%)
FY2019	1.8×	60.88%
FY2018	1.1×	(56.26%)
FY2017	2.6×	9.92%
FY2016	2.3×	(70.67%)

Period	P/S ratio	Change
Sep 2026	0.5×	44.25%
Jun 2026	0.3×	(2.19%)
Mar 2026	0.4×	(21.35%)
Dec 2025	0.5×	(37.08%)
43 more quarters	Free account

Against its own ten years

Low 0.3× High 8.2×

Ten-year median 1.4×

Current reading's percentile 9

Company	P/S ratio
HCM HUTCHMED (China) Limited Sponsored ADR compare	n/m
PRGO Perrigo Company plc	0.5×
ANIP ANI Pharmaceuticals, Inc. compare	1.4×
PBH Prestige Consumer Healthcare Inc. compare	1.8×
TRLV Trulieve Cannabis Corp. compare	2.0×
BCRX BioCryst Pharmaceuticals, Inc. compare	2.0×
ALVO Alvotech compare	4.6×
XERS Xeris Biopharma Holdings, Inc. compare	6.4×
RGC Regencell Bioscience Holdings Limited compare	—
Drug Manufacturers Specialty & Generic industry median	2.1×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Perrigo Company plc (PRGO) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on PRGO

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on PRGO

Stockrow Weekly